PPAR-alpha effects on the heart and other vascular tissues.
about
HVC1 ameliorates hyperlipidemia and inflammation in LDLR-/- mice.Fenofibrate Reduces Age-related Hypercholesterolemia in Normal Rats on a Standard DietDifferential sensitivities of the vascular K(ATP) channel to various PPAR activatorsDanqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway.Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome.The Functions of PPARs in Aging and Longevity.Inhibition of Dexamethasone-induced Fatty Liver Development by Reducing miR-17-5p Levels.Thiazolidinediones and the preservation of beta-cell function, cellular proliferation and apoptosis.Effect of combination treatment of S-amlodipine with peroxisome proliferator-activated receptor agonists on metabolic and cardiovascular parameters in Zucker fa/fa rats.Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids.Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in ratsEffect of peroxisome proliferator-activated receptor gamma agonists on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts.Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.The effect of PPARalpha and PPARgamma ligands on inflammation and ABCA1 expression in cultured gallbladder epithelial cells.Proteomics landscape of radiation-induced cardiovascular disease: somewhere over the paradigm.Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice.PPARα agonist prevented the apoptosis induced by glucose and fatty acid in neonatal cardiomyocytes.PPARα: essential component to prevent myocardial oxidative stress?
P2860
Q33582240-88CC0642-6D65-4F09-993F-BFEE70AF48BFQ33849118-8A1E45F4-C11D-4321-BD87-0B396AF21666Q34044879-4DD1254C-C680-4A0C-B7CB-CF7F8432EF73Q35163413-82C5F75A-5183-432C-90A3-698F20C6F825Q36018562-BF57CC30-01DD-4B86-A711-64F7DCD2D3F7Q36478394-4B2AA9C0-A95E-411C-B171-0CDC23673165Q36756799-A09AAB36-551F-4108-BA5D-E0D350B87185Q36889106-3073ABF6-85F0-45A6-86C8-E39CBC4152AFQ37685266-07E12005-B793-4A09-8BE0-EF60EA118074Q38350181-393D383C-3C7C-4CFD-BE31-A040CA95FE7BQ38674742-0AD329DD-9514-4CB7-9207-5AB4E6B59CD2Q40425308-D55120F4-A410-4BB0-A288-2FA3CC092F96Q41556931-101CE1AA-CD2D-48CE-AE61-FC4636BA28F6Q43247258-9E17894C-AF60-42AA-B4B2-3ED62895EC67Q44643868-72F3461B-9247-4E55-87CC-0F77E77CD42CQ46953942-54A78C37-36C4-45B0-9D92-B09BA91471C0Q47868740-764A86D7-3E66-4456-8219-9E4222C8FF2CQ50451828-D26C4026-352A-4DB4-9258-9F22B8B661A1Q53297388-BF43746D-458D-4168-82D6-7FD70731BDF4Q53332695-7F568E14-0002-460F-9A70-28D96074BD4CQ59200913-CE2AB864-526F-48DC-BCD3-01F6C193CAA4
P2860
PPAR-alpha effects on the heart and other vascular tissues.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
PPAR-alpha effects on the heart and other vascular tissues.
@ast
PPAR-alpha effects on the heart and other vascular tissues.
@en
type
label
PPAR-alpha effects on the heart and other vascular tissues.
@ast
PPAR-alpha effects on the heart and other vascular tissues.
@en
prefLabel
PPAR-alpha effects on the heart and other vascular tissues.
@ast
PPAR-alpha effects on the heart and other vascular tissues.
@en
P2860
P1476
PPAR-alpha effects on the heart and other vascular tissues.
@en
P2093
Gordon A Francis
P2860
P356
10.1152/AJPHEART.01118.2002
P577
2003-03-06T00:00:00Z